What is the initial management for emergency cases of flu-like symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Management of Flu-Like Symptoms

The initial management for emergency cases of flu-like symptoms should include oxygen therapy for hypoxic patients, antiviral treatment with oseltamivir 75 mg twice daily for 5 days if within 48 hours of symptom onset, and appropriate monitoring of vital signs using an Early Warning Score system. 1

Initial Assessment and Monitoring

  • Monitor and document the following vital signs at least twice daily (more frequently in severe cases):

    • Temperature
    • Respiratory rate
    • Pulse
    • Blood pressure
    • Mental status
    • Oxygen saturation
    • Inspired oxygen concentration 2, 1
  • Use an Early Warning Score system for efficient monitoring 1

  • Look for signs of clinical instability:

    • Temperature >37.8°C
    • Heart rate >100/min
    • Respiratory rate >24/min
    • Systolic blood pressure <90 mmHg
    • Oxygen saturation <90%
    • Inability to maintain oral intake
    • Abnormal mental status 1

Oxygen Therapy and Supportive Care

  • Provide oxygen therapy to hypoxic patients with monitoring of oxygen saturations
  • Aim to maintain PaO2 ≥8 kPa and SaO2 ≥92% 2
  • For patients with pre-existing COPD and ventilatory failure, guide oxygen therapy with repeated arterial blood gas measurements 2
  • Consider non-invasive ventilation (NIV) for patients with respiratory failure 2
  • Assess for cardiac complications, volume depletion, and need for intravenous fluids 2, 1
  • Provide nutritional support in severe or prolonged illness 2, 1
  • Ensure adequate fluid intake and rest until fever resolves 1

Antiviral Therapy

  • Initiate oseltamivir treatment if the patient meets all criteria:

    • Acute influenza-like illness
    • Fever >38°C
    • Symptomatic for two days or less 2, 1
  • Dosage:

    • Adults: Oseltamivir 75 mg twice daily for 5 days
    • Reduce dose to 75 mg once daily if creatinine clearance <30 ml/min 2, 1
  • Special considerations:

    • Immunocompromised or elderly patients may benefit from antiviral treatment despite lack of documented fever 2, 1
    • Severely ill hospitalized patients may benefit from antiviral treatment started >48 hours from disease onset, although evidence is limited 2, 3
    • Earlier treatment initiation (within 24 hours) provides greater benefits in reducing illness duration 4, 5

Symptomatic Treatment

  • Acetaminophen: 650-1000 mg every 4-6 hours (maximum 4000 mg/day) for fever and pain relief 1
  • Dextromethorphan: 10-30 mg every 4-8 hours (maximum 120 mg/day) for non-productive cough 1
  • Guaifenesin: 200-400 mg every 4 hours (maximum 2400 mg/day) for productive cough 1
  • Pseudoephedrine: 60 mg every 4-6 hours (maximum 240 mg/day) for nasal congestion (use with caution in patients with hypertension, cardiovascular disease, or glaucoma) 1

Antibiotic Therapy

  • Antibiotics are not routinely required for previously well adults with acute bronchitis complicating influenza 2, 1

  • Consider antibiotics for:

    • Patients with worsening symptoms (recrudescent fever or increasing dyspnea)
    • High-risk patients with lower respiratory features 2, 1
  • When antibiotics are indicated:

    • First-line: Co-amoxiclav or tetracycline (doxycycline)
    • Alternative for penicillin-intolerant patients: Macrolides (clarithromycin/erythromycin) or respiratory fluoroquinolone 1
    • Administer within 4 hours of admission for severe cases 1

Diagnostic Testing

  • For non-severe cases: No routine testing required
  • For severe cases (CURB-65 Score 3-5 or bilateral CXR changes):
    • Blood culture (preferably before antibiotic treatment)
    • Pneumococcal urine antigen
    • Sputum Gram stain, culture, and antimicrobial susceptibility tests
    • Paired serological examination for influenza/other agents
    • Tracheal or endotracheal aspirate samples if available 2

Discharge Criteria and Follow-up

  • Review patients 24 hours prior to discharge

  • Patients should not be discharged if they have two or more of the following:

    • Temperature >37.8°C
    • Heart rate >100/min
    • Respiratory rate >24/min
    • Systolic blood pressure <90 mmHg
    • Oxygen saturation <90%
    • Inability to maintain oral intake
    • Abnormal mental status 2, 1
  • Arrange follow-up for patients who:

    • Suffered significant complications
    • Had significant worsening of underlying disease 2, 1
  • Provide information about illness, medications, and follow-up arrangements at discharge 2, 1

Special Considerations for High-Risk Patients

  • More vigilant monitoring for:

    • Elderly (≥65 years)
    • Children <2 years
    • Patients with chronic medical conditions
    • Immunocompromised individuals
    • Pregnant women 1
  • Consider closer monitoring and potential hospital admission for these high-risk groups 1

References

Guideline

Management of Acute Febrile Illness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Influenza treatment with oseltamivir outside of labeled recommendations.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.